Anúncio
Anúncio

BMY

BMY logo

Bristol-Myers Squibb Co.

52.98
USD
Patrocinado
-0.48
-0.91%
05 de jan., 09:52 UTC -5
Abrir

Relatórios de Lucros BMY

Rácio de surpresa positiva

BMY separação 34 de 39 últimas estimativas.

87%

Próximo Relatório

Data do Próximo Relatório
05 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$12.35B
/
$1.67
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+1.01%
/
+2.45%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+0.03%
/
--

Bristol-Myers Squibb Co. earnings per share and revenue

On 30 de out. de 2025, BMY reported earnings of 1.63 USD per share (EPS) for Q3 25, beating the estimate of 1.52 USD, resulting in a 6.93% surprise. Revenue reached 12.22 bilhão, compared to an expected 11.93 bilhão, with a 2.43% difference. The market reacted with a +7.09% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 21 analistas forecast an EPS of 1.67 USD, with revenue projected to reach 12.35 bilhão USD, implying an aumentar of 2.45% EPS, and aumentar of 1.01% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
logo
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
For Q3 2025, Bristol-Myers Squibb Co. reported EPS of $1.63, beating estimates by 6.93%, and revenue of $12.22B, 2.43% above expectations.
The stock price moved up 7.09%, changed from $42.60 before the earnings release to $45.62 the day after.
The next earning report is scheduled for 05 de fev. de 2026.
Based on 21 analistas, Bristol-Myers Squibb Co. is expected to report EPS of $1.67 and revenue of $12.35B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio